Relay Therapeutics's market cap is currently $1.18B. The company's EPS TTM is $-0.41; its P/E ratio is -3.52; Relay Therapeutics is scheduled to report earnings on August 7, 2025, and the estimated EPS forecast is $-0.41. See an overview of income statement, balance sheet, and cash flow financials.
